Comparative Immunology Microbiology and Infectious Diseases

Comparative Immunology Microbiology and Infectious Diseases is published by Elsevier Ltd and is in Zone 3 of Agricultural & Forestry Sciences in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Viral Infections and Vectors, Animal Disease Management and Epidemiology and Herpesvirus Infections and Treatments, together about 20% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

An International Journal focused on Comparative Veterinary and Medical ResearchComparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine - One Health" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .CIMID is mainly focusing on applied veterinary medicine with a particular focus on zoonotic pathogens. It includes etiology, biology, clinical diseases, epidemiology, diagnosis, control. Experimental in vitro studies and studies on laboratory animals are generally not accepted. Non infectious diseases are not accepted. Specific focus on human diseases can only be accepted if it concerns major zoonotic pathogens. Reviews are generally not accepted, except if they contain new or recent developments. CIMID does not accept manuscript focusing on Mycology.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial and parasitic diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals and/or can serve as a model for human diseases). Papers dealing primarily with epidemiology will be considered if they demonstrate a clear impact on the clinical features, pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, parasitology, immunology or pathogenesis must address issues of comparative medical interest. Manuscripts focusing on probiotics or diseases and/or immunology of fishes are not part of our overall scope, as they are better fitted to more specialized journals. Manuscripts dealing with food hygiene and food risk are not part of our overall scope. Manuscripts dealing strictly with experimental design and fundamental research may not be considered depending the overall consequences for the knowledge of a disease.Review articles can be accepted. They should focus either on a pathogen or on analyses of the mechanisms of host-pathogen interactions including epidemiological studies. Proposal for such manuscripts should be submitted to the Co-Editors in Chief for approval before submitting the manuscript.Papers focusing solely on diagnostic techniques, case reports or drug trials will generally not be accepted. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).Instruction for Authors:Comparative Immunology, Microbiology & Infectious Diseases consists of six issues a year and publishes original papers or reviews of the status of current research relative to the different

From the journal's Aims & Scope

Research area (LetPub): Immunology

Editor-in-chief Frederic Beugnet LyonPublisher website

Editorial board by country: 5 in mainland China (about 28%); most named Mainland China 5, United States 5, France 5, United Kingdom 2, South Africa 1 (18 members with a country) Editorial board ↗Publisher website · 2026-10-01

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.41LetPub · 2026-09-13

Impact factor (publisher)

2.5Publisher website · 2026-10-01

CiteScore 2026-06

4.4LetPub · 2026-09-13

CiteScore (publisher)

4.4Publisher website · 2026-10-01

SJR 2026-06

0.6LetPub · 2026-09-13

SNIP 2026-06

0.92LetPub · 2026-09-13

h-index

48LetPub · 2026-09-13

h-index

87OpenAlex · 2026-10-01

i10-index

1,356OpenAlex · 2026-10-01

2-year mean citedness

2.23OpenAlex · 2026-10-01

Self-citation rate

4%LetPub · 2026-09-13

Share of gold OA articles

12.99%LetPub · 2026-09-13

Volume

Articles per year

75LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 3 monthsLetPub · 2026-09-13

Average acceptance (community reports)

25%LetPub · 2026-09-13

Submission to first decision

7 daysPublisher website · 2026-10-01

First decision after review

40 daysPublisher website · 2026-10-01

Submission to acceptance

66 daysPublisher website · 2026-10-01

Acceptance to publication

3 daysPublisher website · 2026-10-01

Peer review

Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Elsevier Ltd

Country or region

ENGLAND

Language

Multi-Language

Frequency

Bimonthly

Founded

1978

ISSN

0147-9571

Electronic ISSN

1878-1667

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗Publisher website
• Special issues ↗Publisher website